Jonathan Freeman
Direttore/Membro del Consiglio presso PHIO PHARMACEUTICALS CORP.
Patrimonio netto: 2 259 $ in data 30/04/2024
Profilo
Jonathan E.
Freeman is the founder of Anthos Therapeutics, Inc. founded in 2021, where he holds the title of Chief Operating Officer.
He is currently an Independent Director at Phio Pharmaceuticals Corp.
since 2017 and a Senior Advisor at Blackstone Life Sciences Advisors LLC since 2018.
Previously, he worked as a Director-Mergers & Acquisitions at Baxter Healthcare Corp.
from 2005 to 2008, Director & Vice President at Swiss-PLG, Head-Licensing at EMD Serono, Inc. from 1999 to 2005, Chief Business Officer at Vedanta Biosciences, Inc., and Senior Vice President & Head-Strategy Development at Merck KGaA from 2013 to 2016.
He has an undergraduate and graduate degree from the University of Cambridge and an MBA from Webster University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2024 | 3 200 ( 0.07% ) | 2 259 $ | 30/04/2024 |
Posizioni attive di Jonathan Freeman
Società | Posizione | Inizio |
---|---|---|
PHIO PHARMACEUTICALS CORP. | Direttore/Membro del Consiglio | 07/06/2017 |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Fondatore | 01/07/2021 |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Consulente / Consigliere | 01/11/2018 |
Precedenti posizioni note di Jonathan Freeman
Società | Posizione | Fine |
---|---|---|
MERCK KGAA | Corporate Officer/Principal | 01/01/2016 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/2008 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2005 |
Swiss-PLG | Direttore/Membro del Consiglio | - |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Jonathan Freeman
University of Cambridge | Graduate Degree |
Webster University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK KGAA | Health Technology |
PHIO PHARMACEUTICALS CORP. | Health Technology |
Aziende private | 6 |
---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Swiss-PLG | |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Freeman